<style face="normal" font="default" size="100%">Tau protein squired by molecular chaperones during alzheimer's disease</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Tau protein squired by molecular chaperones during alzheimer's disease</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Molecular cobalt(II) complexes for tau polymerization in Alzheimer's disease</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Autophagic pathways to clear the tau aggregates in alzheimer's disease</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Basic limonoid modulates chaperone-mediated proteostasis and dissolve Tau fibrils</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">EGCG impedes human Tau aggregation and interacts with Tau</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6*and AcPHF6</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Transition metal nickel prevents Tau aggregation in Alzheimer's disease</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Implications of valosin-containing protein in promoting autophagy to prevent tau aggregation</style>